Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Johnson & Johnson (

Johnson & Johnson Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Johnson & Johnson's underperformance relative to the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook about the stock’s prospects.

2 Dividend Kings You Should Snap Up Immediately

2 Dividend Kings You Should Snap Up Immediately

Recent earnings from these dividend-paying companies reflects their stability.

How tech leaders are rethinking their cloud strategies in the face of fast-rising costs

How tech leaders are rethinking their cloud strategies in the face of fast-rising costs

As spending on cloud computing rises sharply amid the generative AI boom, executives are on the hunt for cost savings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Stocks Upgraded by Bank of America – Here's Why They're Bullish

Bank of America analysts have recently shifted their views on these three stocks, leaving investors with a few points to consider.

Technology Stocks Upended by China’s DeepSeek

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -1.46%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.97%. March E-mini S&P futures (ESH25 ) are down by -1.38%, and March E-mini Nasdaq...

Why Traders Are Buying the Dip on Johnson & Johnson Stock

Shares of Johnson & Johnson stock have declined by 11.5% in the quarter, and markets are calling for a bottom and rally here.

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

inkl

Read news from The Economist, FT, and more,
with one subscription

Ketamine-derived nasal spray for depression now FDA-approved as stand-alone treatment

Ketamine-derived nasal spray for depression now FDA-approved as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Stocks March Higher as Netflix and Oracle Soar

Stocks March Higher as Netflix and Oracle Soar

The S&P 500 Index ($SPX ) (SPY ) today is up +0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. March E-mini S&P futures (ESH25 ) are up +0.52%, and March E-mini Nasdaq futures...

Is Johnson & Johnson Stock Set to Reward Long-Term Holders?

Is Johnson & Johnson Stock Set to Reward Long-Term Holders?

JNJ stock is up 1.8% after announcing its $14.6 billion acquisition of Intra-Cellular Therapeutics, which may make this undervalued dividend king attractive

Stock market today: Asian shares trade mixed after drops for Big Tech leave Wall Street mixed

Stock market today: Asian shares trade mixed after drops for Big Tech leave Wall Street mixed

Asian shares are mixed after gains for oil-and-gas producers helped offset drops for Nvidia and other Big Tech companies on Wall Street

The Independent UK

World’s largest proteins study ‘invaluable’ for understanding disease – experts

World’s largest proteins study ‘invaluable’ for understanding disease – experts

The scaled-up project is backed by a consortium of 14 pharmaceutical firms.

Evening Standard

Largest ever protein study set to revolutionise cancer and dementia tests

Largest ever protein study set to revolutionise cancer and dementia tests

Tens of millions of pounds in investment is being provided by the group of firms which includes AstraZenecaa and Pfizer

The Independent UK

Top 3 Discounted Dividend Stocks for 2025 That Could Skyrocket Your Portfolio

Top 3 Discounted Dividend Stocks for 2025 That Could Skyrocket Your Portfolio

These three companies are leaders in their field, have a long history of increasing their dividends, and the stocks trade at a discount.

Get all your
news in one place.

100’s of premium titles.
One news app.

Johnson & Johnson's Quarterly Earnings Preview: What You Need to Know

Johnson & Johnson is poised to release its fiscal fourth-quarter earnings this month, and analysts project a double-digit profit decline.

The Independent UK

‘I felt betrayed’: Woman blames cancer diagnosis on talcum powder use

Exclusive: Jane Campbell is one of thousands of women in the UK planning legal action against one of the world’s largest pharmaceutical firms over alleged links between talc and cancer

The Independent UK

Man sues Johnson & Johnson for $25m claiming talcum powder killed his wife

The lawsuit, filed in Maine, claims Cynthia Cartwright ingested asbestos while using the product, Pecos River Talc, which is a subsidiary of the pharmeceutical giant

Pharmaceutical giant sued over 'ineffective' cold drugs

Pharmaceutical giant Johnson & Johnson is facing a class action concerning cold and flu medication known to be "ineffective".

Get all your
news in one place.

100’s of premium titles.
One news app.

Ray Dalio's Bridgewater Adds Broadcom, Apple, SMCI In Q3, While Offloading Stake In AI Giant Nvidia And Other Big Tech Companies

Bridgewater Associates, the world's biggest hedge fund, sold top AI-linked stocks like Nvidia, Alphabet, Microsoft, Amazon, and Johnson & Johnson.

International Business Times

Johnson & Johnson Risks UK Lawsuit Over Talc Cancer Claim

UK claimants announced Wednesday legal action against US pharmaceutical and cosmetics giant Johnson & Johnson, alleging that women diagnosed with cancers were exposed to asbestos in the company's talcum powder.

Evening Standard

Thousands of women plan legal action over alleged links between talc and cancer

If the action goes ahead it is understood to be the first of its kind against Johnson & Johnson in the UK.

Are Wall Street Analysts Predicting Johnson & Johnson Stock Will Climb or Sink?

Johnson & Johnson has struggled to keep up with the broader market over the past year, and analysts are cautiously bullish on its future potential.

3 Highest-yielding Dividend Kings for Maximum Income and Stability

Looking for reliable yield? These three companies offer ever-increasing dividends and a lifetime of stability.

Johnson & Johnson's Q3 2024 Earnings: What to Expect

Johnson & Johnson is all set to announce its third-quarter results this month, and analysts are projecting double-digit earnings decline.

Johnson & Johnson Subsidiary Files For Bankruptcy For Third Time

Johnson & Johnson subsidiary files for bankruptcy to settle talc-related cancer lawsuits. Proposed billion settlement faces legal challenges.

People

156,264 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Bank of America

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

325,531 stories

127,832 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play